127 related articles for article (PubMed ID: 25709104)
1. [Tumour markers in chronic kidney disease].
Mercadal L
Nephrol Ther; 2015 Apr; 11(2):122-4. PubMed ID: 25709104
[TBL] [Abstract][Full Text] [Related]
2. The efficacy of serum carcinoembryonic antigen (CEA), cancer antigen 125 (CA125), carbohydrate antigen 19-9 (CA19-9), carbohydrate antigen 15-3 (CA15-3), alpha-fetoprotein (AFP) and human chorionic gonadotropin (hCG) levels in determining the malignancy of solitary pulmonary nodules.
Bekci TT; Senol T; Maden E
J Int Med Res; 2009; 37(2):438-45. PubMed ID: 19383238
[TBL] [Abstract][Full Text] [Related]
3. Immunocytochemical evaluation of human esophageal neoplasms and preneoplastic lesions for beta-chorionic gonadotropin, placental lactogen, alpha-fetoprotein, carcinoembryonic antigen, and nonspecific cross-reacting antigen.
Burg-Kurland CL; Purnell DM; Combs JW; Hillman EA; Harris CC; Trump BF
Cancer Res; 1986 Jun; 46(6):2936-43. PubMed ID: 2421889
[TBL] [Abstract][Full Text] [Related]
4. [A case of alpha-fetoprotein, carcinoembryonic antigen and human chorionic gonadotropin producing renal cell carcinoma].
Takakura N; Mimura H; Hamazaki K; Kim H; Hirata K; Miwata H; Kimura T; Sakata T; Hosoba T; Orita K
Gan No Rinsho; 1987 Sep; 33(11):1385-90. PubMed ID: 2444728
[TBL] [Abstract][Full Text] [Related]
5. Serum tumour markers in patients with chronic kidney disease.
Xiaofang Y; Yue Z; Xialian X; Zhibin Y
Scand J Clin Lab Invest; 2007; 67(6):661-7. PubMed ID: 17852811
[TBL] [Abstract][Full Text] [Related]
6. Tumor markers in hemodialysis patients.
Arican A; Ozdemir N; Sezer S; Erten Y; Güz G; Turan M; Inanoglu I; Haberal M
Transplant Proc; 1999 Dec; 31(8):3367-8. PubMed ID: 10616509
[No Abstract] [Full Text] [Related]
7. The importance of serum and ascites fluid alpha-fetoprotein, carcinoembryonic antigen, CA 19-9, and CA 15-3 levels in differential diagnosis of ascites etiology.
Sari R; Yildirim B; Sevinc A; Bahceci F; Hilmioglu F
Hepatogastroenterology; 2001; 48(42):1616-21. PubMed ID: 11813585
[TBL] [Abstract][Full Text] [Related]
8. [Carcinoembryonic antigen, alpha-fetoprotein and human chorionic gonadotropin producing gastric cancer].
Honda T; Katusima S; Tokuda Y; Matuda K; Oonisi Y; Taniguchi T; Oomoto J; Kawaguchi Y
Nihon Naika Gakkai Zasshi; 1984 Apr; 73(4):521-6. PubMed ID: 6206171
[No Abstract] [Full Text] [Related]
9. Review of Commonly Used Serum Tumor Markers and Their Relevance for Image Interpretation.
Reiter MJ; Costello JE; Schwope RB; Lisanti CJ; Osswald MB
J Comput Assist Tomogr; 2015; 39(6):825-34. PubMed ID: 26248153
[TBL] [Abstract][Full Text] [Related]
10. Germ cell tumor in the basal ganglia: immunohistochemical demonstration of alpha-fetoprotein, human chorionic gonadotropin, and carcinoembryonic antigen.
Ono N; Inoue HK; Naganuma H; Misumi S; Tamura M
Surg Neurol; 1986 May; 25(5):495-500. PubMed ID: 2421426
[TBL] [Abstract][Full Text] [Related]
11. Optimal combination of seven tumour markers in prediction of advanced stage at first examination of patients with non-small cell lung cancer.
Ando S; Kimura H; Iwai N; Shima M; Ando M; Kuriyama T
Anticancer Res; 2001; 21(4B):3085-92. PubMed ID: 11712815
[TBL] [Abstract][Full Text] [Related]
12. [Studies on the tumor markers in the germinal testicular tumors. Cellular localization of alpha-fetoprotein (AFP), human chorionic gonadotropin (HCG) and carcinoembryonic antigen (CEA) in germinal testicular tumors using an indirect immunoperoxidase method].
Miki T
Nihon Hinyokika Gakkai Zasshi; 1984 Mar; 75(3):503-22. PubMed ID: 6206269
[No Abstract] [Full Text] [Related]
13. Tumour markers in gynaecologic oncology.
Onsrud M
Scand J Clin Lab Invest Suppl; 1991; 206():60-70. PubMed ID: 1719611
[TBL] [Abstract][Full Text] [Related]
14. Impact of chronic kidney disease on serum tumor markers concentrations.
Tong HL; Dong ZN; Wen XY; Gao J; Wang B; Tian YP
Chin Med J (Engl); 2013 Jan; 126(2):274-9. PubMed ID: 23324276
[TBL] [Abstract][Full Text] [Related]
15. Serum tumor markers in patients on dialysis and kidney transplantation.
Lye WC; Tambyah P; Leong SO; Lee EJ
Adv Perit Dial; 1994; 10():109-11. PubMed ID: 7528056
[TBL] [Abstract][Full Text] [Related]
16. Advances in biological markers for cancer.
Klavins JV
Ann Clin Lab Sci; 1983; 13(4):275-80. PubMed ID: 6194735
[TBL] [Abstract][Full Text] [Related]
17. Serum tumor markers in advanced stages of chronic kidney diseases.
Rani BS; Suchitra MM; Srinivasa Rao PVLN; Kumar VS
Saudi J Kidney Dis Transpl; 2019; 30(4):898-904. PubMed ID: 31464247
[TBL] [Abstract][Full Text] [Related]
18. Interlaboratory surveys of the determination of tumour markers scatter and repeatability of the results.
Kruse R; Geilenkeuser WJ; Röhle G
Eur J Clin Chem Clin Biochem; 1993 Mar; 31(3):139-46. PubMed ID: 7683915
[TBL] [Abstract][Full Text] [Related]
19. Serum tumor markers.
Klee GG; Go VL
Mayo Clin Proc; 1982 Feb; 57(2):129-32. PubMed ID: 6172679
[No Abstract] [Full Text] [Related]
20. Prognostic Value of Carcinoembryonic Antigen (CEA), AFP, CA19-9 and CA125 for Patients with Colorectal Cancer with Peritoneal Carcinomatosis Treated by Cytoreductive Surgery and Intraperitoneal Chemotherapy.
Huo YR; Huang Y; Liauw W; Zhao J; Morris DL
Anticancer Res; 2016 Mar; 36(3):1041-9. PubMed ID: 26976996
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
